We use GEPIA2 (http://gepia2.cancer-pku.cn/#index) to analyze The Cancer Genome Atlas (TCGA) data and find that MIR200CHG is upregulated in breast cancer (Fig. 1b), and there are differences in expression between the molecular subtypes (Fig. 1c). Here, MIR200CHG is linked to breast carcinoma.